Prenatal and Newborn Genetic Testing Market Report to 2027

Prenatal and Newborn Genetic Testing Market to 2027 - Global Analysis and Forecasts By Product (Diagnostic, and Screening), Disease (Cystic Fibrosis, Sickle Cell Anemia, Downs Syndrome, Phenylketonuria, and Other Disease), End User (Hospitals and Clinics, Diagnostic Centers, and Other End User) and Geography

Publication Month : Jul 2019

  • Report Code : TIPBT00002550
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 194
Inquire Before Buy




[Research Report] The prenatal and newborn genetic testing market was valued at US$ 4,034.4 million in 2018 and it is projected to reach US$ 11,204.7 million in 2027; it is expected to grow at a CAGR of 12.2% from 2019 to 2027.

Prenatal genetic testing is performed during the pregnancy for the diagnosis of the diseases or detection of specific genetic abnormalities before 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Most of the prenatal genetic tests use a blood sample from the mother for conduction of various screens. Diagnostic methods are more effective, accurate, and a preferred option for the detection of chromosome abnormalities as compared to the screening methods. The growth of the global prenatal and newborn genetic testing market is attributed to the increase in the prevalence of genetic diseases among infants, supportive government for promoting the use of prenatal and newborn testing and increasing birth rate. However, risk associated with prenatal genetic tests is the major factor hindering the market growth.

The global prenatal and newborn genetic testing market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global Prenatal and Newborn Genetic Testing Market

Lucrative Regions for Global Prenatal and Newborn Genetic Testing Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

High Prevalence of Genetic Diseases in Infants to Drive Global Prenatal and Newborn Genetic Testing Market Growth

Several types of genetic diseases affect the fetuses in the womb. The way in which these genetic diseases are inherited helps to determine the risk that they pose on pregnancy as well as the risk of its recurrence. The risk of having genetic diseases in babies is high in cases where the parents have another child with a genetic disease, family history of a genetic disorder, or if either of a parent has a chromosomal abnormality. There is a significant prevalence of genetic diseases among infants. Moreover, these diseases are also responsible for infant mortality across the globe. For instance, according to the World Health Organization 2016, an estimated 7.9 million infants across world are born with genetic defects. Moreover, according to the Centers for Disease Control and Prevention (CDC), birth defects affects every 1 in 33 babies born in the US. On the other hand, chromosomal abnormalities such as Down syndrome affects 1 in 691 babies born in the US, as per the CDC’s data in 2017. 

On the other hand, a survey conducted by John Hopkins University in 2015 states that approximately 20-30% of infant deaths are a result of genetic disorders. Some of the major genetically determined metabolic diseases include sickle cell anemia, phenylketonuria, thalassemia, and others. Down syndrome is the most common chromosomal disorder that affects around 6000 babies in the US, according to the CDC’s statistics. Moreover, according to a report published by Stanford’s Children Health in 2018, sickle cell anemia occurs in almost 1 out 365 black African-American births. Thus, the high prevalence of genetic diseases among infants account for the increasing demands for prenatal and newborn genetic tests, thereby contributing to the growth of the market.

Product -Based Insights

In terms of product, the global prenatal and newborn genetic testing market is segmented into screening and diagnostics. In 2018, the screening segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

Global Prenatal and Newborn Genetic Testing Market, by Product– 2018 and 2027

Global Prenatal and Newborn Genetic Testing Market, by Product– 2018 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Disease Indication-Based Insights

In terms of disease indication, the global prenatal and newborn genetic testing market is segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria and other diseases. In 2018, the down syndrome segment held largest share of the market. However, the cystic fibrosis segment is expected to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the global prenatal and newborn genetic testing market is segmented into hospitals & clinics, diagnostic centers and other end user. The hospitals and clinics segment held the largest share of the market in 2018. However, the diagnostics segment is estimated to grow at the fastest rate during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Prenatal and Newborn Genetic Testing Market: Strategic Insights

Market Size Value inUS$ 4,034.4 Million in 2018
Market Size Value byUS$ 11,204.7 Million by 2027
Growth rateCAGR of 12.2% from 2019-2027
Forecast Period2019-2027
Base Year2019
Analyst Image


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The global prenatal and newborn genetic testing market players are adopting the product launches, partnerships, and acquisitions to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global Prenatal and Newborn Genetic Testing Market – by Product

  • Diagnostic  
  • Spectrophotometer
  • Polymerase Chain Reaction
  • Fluorescence in-situ Hybridization
  • Array-Comparative Genomic Hybridization
  • Screening
  • Maternal Serum Screening
  • Chronic Villus Sampling
  • Amniocentesis
  • Non-invasive Prenatal Testing

Global Prenatal and Newborn Genetic Testing Market – by Disease Indication

  • Cystic Fibrosis
  • Sickle Cell Anemia
  • Down Syndrome
  • Phenylketonuria
  • Other Diseases

Global Prenatal and Newborn Genetic Testing Market – by End- User

  • Hospitals & Clinics
  • Diagnostic Centres
  • Other End Users

Global Prenatal and Newborn Genetic Testing Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Abbott
  • Quest Diagnostics Incorporated
  • Ravgen
  • Bio-Rad Laboratories, Inc.,
  • Illumina, Inc.
  • F. Hoffmann La-Roche Ltd.
  • Qiagen
  • Berry Gene
  • PerkinElmer, Inc.
  • Natera, Inc.
  • Laboratory Corporation of America Holdings (Sequenom)
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product , Disease , End User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List of Companies

  1. Abbott
  2. Quest Diagnostics Incorporated
  3. Ravgen
  4. Bio-Rad Laboratories, Inc.
  5. Illumina, Inc.
  6. F. Hoffmann La-Roche Ltd.
  7. Qiagen
  8. Berry Gene
  9. PerkinElmer, Inc.
  10. Natera, Inc.
  11. Laboratory Corporation of America Holdings (Sequenom)

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Prenatal and Newborn Genetic Testing Market